PATENT CLAIM ANALYSIS

Application Number: 15923050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "017700"]

Abstract:
Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.

Claim (Index 58):
The method of  claim 52 , wherein said netupitant occupies at least 70% of said patient's striatum NK1 receptors seventy-two hours after said administration.

Metadata:
- Claim Count in Document: 212.0
- Percentile: 90.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14069927', '13077462', '15003327', '14069970', '14069885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8535380723459293
- 35 USC 102 Novelty (BERT): 0.698613329340425
- Combined Prediction Score: 0.8380455980453788
- Mean Citation Score: 677.586414
- Max Citation Score: 749.77997
- Similarity Product: 702.3890069339508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test